Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-28T16:12:54.006Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of clonidine pre-treatment on bupivacaine and ropivacaine cardiotoxicity in rats

Published online by Cambridge University Press:  23 December 2004

S. Gulec ,
Y. Aydin ,
K. Uzuner ,
B. Yelken  and
Y. Senturk
S. Gulec
Affiliation:
Osmangazi University Medical School, Department of Anaesthesiology, Eskisehir, Turkey
Y. Aydin
Affiliation:
Osmangazi University Medical School, Department of Physiology, Eskisehir, Turkey
K. Uzuner
Affiliation:
Osmangazi University Medical School, Department of Physiology, Eskisehir, Turkey
B. Yelken
Affiliation:
Osmangazi University Medical School, Department of Anaesthesiology, Eskisehir, Turkey
Y. Senturk
Affiliation:
Osmangazi University Medical School, Department of Anaesthesiology, Eskisehir, Turkey
Get access

Abstract

Summary

Background and objective: Clonidine has cardiac and systemic effects that can modify the potentially lethal cardiovascular effects of local anaesthetics. We evaluated the effects of clonidine pre-treatment on cardiotoxicity induced by an infusion of bupivacaine or ropivacaine and the success rate of resuscitation in anaesthetized rats.

Methods: Thirty-two Sprague–Dawley rats (250–300 g) were anaesthetized with thiopental and ketamine. Lung ventilation was maintained mechanically, and the electrocardiograph and invasive blood pressure were recorded continuously. Two separate groups of rats were treated with intravenous clonidine 5 μg kg−1 (n = 16) or saline (n = 16) in a randomized fashion. Fifteen minutes later, each group was randomly subdivided into two equal groups and an infusion of bupivacaine or ropivacaine, 3 mg kg−1 min−1, was given until cardiac arrest (asystole) occurred. The times when the cardiotoxic events (25%, 50% and 75% reduction of arterial pressure and heart rate, first dysrhythmia and asystole, respectively), induced by the local anaesthetic, occurred and the resuscitation outcome scores were recorded.

Results: Clonidine reduced heart rate and arterial pressure (P < 0.01). Clonidine did not alter cardiotoxicity or the success rate of resuscitation in bupivacaine-treated rats. In the ropivacaine group, clonidine increased the 25%, 50% and 75% reduction times of arterial pressure and the 50% and 75% reduction times of heart rate, times to first dysrhythmia and asystole (P < 0.05). Clonidine also increased the success rate of resuscitation in ropivacaine-treated rats (P < 0.05).

Conclusions: Although pre-treatment with clonidine protects the effects of ropivacaine cardiotoxicity and increases the success rate of resuscitation, it does not affect bupivacaine toxicity.

Keywords

LOCAL ANAESTHETICS, bupivacaine, ropivacaineCARDIOVASCULAR AGENTS, clonidineDRUG TOXICITY
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 21 , Issue 3 , March 2004 , pp. 205 - 209
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albright GA. Cardiac arrest following regional anaesthesia with etidocaine or bupivacaine. Anesthesiology 1979; 51: 285–287.Google Scholar
Reiz S, Haggmark S, Johansson G, Nath S. Cardiotoxicity of ropivacaine – a new amide local anaesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93–98.Google Scholar
Gaumann DM, Tassonyi E, Rivest RW, Fathi M, Reverdin AF. Cardiovascular and endocrine effects of clonidine premedication in neurosurgical patients. Can J Anesth 1991; 38: 837–843.Google Scholar
Carabine UA, Wright PMC, Moore J. Preanaesthetic medication with clonidine: a dose-response study. Br J Anaesth 1991; 67: 79–83.Google Scholar
De la Coussaye JE, Bassoul B, Brugada J, et al. Reversal of electrophysiologic and hemodynamic effects induced by high dose of bupivacaine by the combination of clonidine and dobutamine in anesthetized dogs. Anesth Analg 1992; 74: 703–711.Google Scholar
De Kock M, Le Polain B, Henin D, Vandewalle F, Scholtes JL. Clonidine pre-treatment reduces the systemic toxicity of intravenous bupivacaine in rats. Anesthesiology 1993; 79: 282–289.Google Scholar
Heath ML. Deaths after intravenous regional anaesthesia. Br Med J 1982; 285: 913–914.Google Scholar
Bruguerolle B, Attolini L, Lorec AM, Gantenbein M. Kinetics of bupivacaine after clonidine pretreatment in mice. Can J Anesth 1995; 42: 434–437.Google Scholar
Dabadie P, Bendriss P, Erny P, Mazat P. Uncoupling effects of local anaesthetics on rat liver mitochondria. FEBS Lett 1987; 226: 77–82.Google Scholar
Chazotte B, Vanderkooi G. Multiples sites of inhibition of mitochondria electron transport by local anaesthetics. Biochim Biophys Acta 1981; 636: 153–161.Google Scholar
Karniel M, Beitner N. Local anesthetic induce a decrease in the level of glucose 1,6-bisphospate, fructose 1,6-bisphospate, and ATP, and in the viability of melanoma cells. Mol Genet Metab 2000; 69: 40–45.Google Scholar
Sztark F, Tueux O, Erny P, Dabadie P, Mazat JP. Effect of bupivacaine on cellular oxygen consumption and adenine nucleotide metabolism. Anesth Analg 1994; 78: 335–339.Google Scholar
Eledjam JJ, de La Coussaye JE, Brugada J, et al. In vitro study on mechanisms of bupivacaine-induced depression of myocardial contractility. Anesth Analg 1989; 69: 732–735.Google Scholar
Sztark F, Malgat M, Dabadie P, Mazat JP. Comparison of the effects of bupivacaine and ropivacaine on heart cell mito-chondria bioenergetics. Anesthesiology 1998; 88: 1340–1349.Google Scholar
Scutari G, Marian M, Nindoli A, et al. Mitochondrial effects of L-ropivacaine, a new local anesthetic. Biochem Pharmacol 1998; 56: 1633–1637.Google Scholar
Takayanagi I, Onozuka S. Greater tension is developed at the same level of cytosolic Ca2+ concentration in the presence of clonidine, an adrenergic partial agonist, than in the presence of norepinephrine. J Pharmacobiodyn 1989; 12: 781–786.Google Scholar
Takayanagi I, Onozuka. Alpha 1-adrenergic partial agonists utilise cytosolic Ca2+ more effectively for contraction in aortic smooth muscle. Can J Physiol Pharmacol 1990; 68: 1329–1333.Google Scholar
Mio Y, Fukuda N, Kusakari Y, Tanifuji Y, Kurihara S. Bupivacaine attenuates contractility by decreasing sensitivity of myofilaments to Ca2+ in rat ventricular muscle. Anesthesiology 2002; 97: 1168–1177.Google Scholar
Brown CG, Jenkins J, Werman HA, Van Ligten P, Ashton J, Hamlin RL. The effect of UK14,304-18 (an alpha-2 adrenergic agonist) on myocardial blood flow during cardio-pulmonary resuscitation. Resuscitation 1989; 17: 243–250.Google Scholar
Sun S, Weil MH, Tang W, Kamohara T, Klouche K. Alpha-methylnorepinephrine, a selective alpha-2 adrenergic agonist for cardiac resuscitation. J Am Coll Cardiol 2001; 37: 951–956.Google Scholar
Kloucke K, Weil MH, Tang W, Povoas H, Kamohara T, Bisera J. A selective alpha-2 adrenergic agonist for cardiac resuscitation. J Lab Clin Med 2002; 140: 27–34.Google Scholar
Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. New Engl J Med 2001; 345: 588–594.Google Scholar